Bioventus Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Bioventus Inc. | BVS - NASDAQ |
$16.00-$18.00 | $13.00 | $15.10 | 8 million | 2/11/2021 |
| Morgan Stanley, JP Morgan, Goldman Sachs | ||||||
Co-Manager(s): Canaccord Genuity | ||||||
| Health Care | ||||||
Filing(s): 1st Filed 2016-06-30 Terms Added 2016-07-19 Filed 2021-01-20 Terms Added 2021-02-04 | ||||||
Bioventus Inc. Quote & Chart - Click for current quote - BVS
IPO Boutique aggregates information on public companies and private companies, such as "BVS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Bioventus Inc. (adapted from Bioventus Inc. prospectus):
They are a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body’s natural healing process.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body’s natural healing process.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "BVS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.